Ticker

The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

The State Street SPDR S&P Pharmaceuticals ETF (XPH) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.

The United States and China traded barbs at a U.N. drugs meeting on Monday, with Washington accusing Beijing of failing to stop sales of precursor ​chemicals for fentanyl and China dismissing the allegation as false while calling ‌the U.S. irresponsible.

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH - Get Free Report) was the recipient of a large growth in short interest in February. As of February 13th, there was short interest totaling 781,872 shares, a growth of 21.1% from the January 29th total of 645,905 shares. Based on an average daily volume of 119,993 shares, the days-to-cover

Not every exchange-traded fund (ETF) worth owning trades at a premium. Some of the most structurally sound funds sit quietly below the radar, offering low costs, reliable income, or sector exposure that the broader market has yet to reprice fully.